focus -WSS

focus

author：hotspot 2025-10-01 17:21:34 - browse：86

UnitedHealth's CEO Andrew Witty stares into the camera at a hearing with his fingers locked — politics coverage from STAT — Kent Nishimura/Getty Images

You’re reading the web version of Health Care Inc., STAT’s weekly newsletterfollowing the flow of money in medicine. Sign upto get it in your inbox every Monday.

About that 90,000 number

UnitedHealth Group CEO Andrew Witty faced Congress last week, where lawmakers pressed him on the Change Healthcare cyberattack (my colleague Brittany Trang watched the hearings closely and tried to break down what it all means). There was one particular exchange that’s worth highlighting.

To illustrate how large UnitedHealth has become, Sen. Elizabeth Warren (D-Mass.) cited how the company is the largest employer or “controller” of physicians, with 90,000 — roughly 10% of all U.S. physicians. Witty felt compelled to clarify that number.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： BioMarin wins approval for gene therapy to treat hemophilia A
Next article： Covid vaccine financial winners and losers, from Pfizer to Novavax

WSS

The Harvard botanist who searched for psychedelics in the Amazon

Readout Newsletter: Cardior, Regeneron, Nuvation, Dyne and more

Merck drug for rare lung condition set for approval in U.S.

There's no autism epidemic. It's an autism diagnosis epidemic

Readout Newsletter: Wegovy, dialysis, Humira, Vir, and more

Readout Newsletter: Alnylam, Celldex, Roche, Zealand Pharma

leisure time

focus

About that 90,000 number

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

explore

Medicare details structure of new drug price negotiation program

The Readout: Abbvie and Humira, CRISPR in utero, Annovis Bio

Novavax promises a turnaround & Lilly roils the obesity market

New documents shed light on MD Anderson Cancer Institute feud

In age of alternative facts, a scholarly course on calling out crap

Annovis Bio delivers candor, but not confidence, on Parkinson’s study

New air purifier tech could be key to improving indoor air quality

Readout Newsletter: Wegovy, dialysis, Humira, Vir, and more

Peter Hotez and the public health issue of online harassment

Abortion pill case raises question: who can sue the FDA?

entertainment

Scientists boost immune system in aging mice by making it youthful

New documents shed light on MD Anderson Cancer Institute feud

He's a Nobel laureate. Critics say he was misleading on Covid

Washington mulls new rules to avert another Change Healthcare

Medicare inequities exacerbate Puerto Rico’s health disparities

NIH study of ME/CFS points to clear biological hallmarks

entertainment

explore

hotspot

leisure time